Ovoca Bio plc (OVB.L)
GBp 1.6
(3.23%)
GBp 1.6
(3.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 5.09 Million | 5.42 Million | 5.86 Million | 2.2 Million | 2.31 Million | 1.82 Million |
| Selling, General and Administrative Expenses | 1.86 Million | 2.05 Million | 1.98 Million | 888 Thousand | 797 Thousand | 589 Thousand |
| Research and Development Expenses | 419 Thousand | 2.45 Million | 3.55 Million | 688 Thousand | 619 Thousand | 357 Thousand |
| Other Expenses | 2.81 Million | 1.45 Million | 325 Thousand | 629 Thousand | 899 Thousand | 876 Thousand |
| Cost and Expenses | 5.09 Million | 5.42 Million | 5.86 Million | 2.2 Million | 2.31 Million | 1.82 Million |
| Operating Income | -5.09 Million | -5.57 Million | -5.33 Million | -2.53 Million | -2.28 Million | -2.43 Million |
| Interest Expense | - | 39 Thousand | 21 Thousand | 16 Thousand | 23 Thousand | 10 Thousand |
| Income Tax Expense | - | 336 Thousand | 249 Thousand | 30 Thousand | -312 Thousand | 844 Thousand |
| Earnings before Tax | -5.1 Million | -5.61 Million | -5.24 Million | -2.31 Million | -1.9 Million | -1.99 Million |
| Net Income | -4.7 Million | -5.61 Million | -5.49 Million | -2.34 Million | -1.59 Million | -2.35 Million |
| Earnings Per Share Basic | -0.07 | -0.07 | -0.07 | -0.03 | -0.02 | -0.03 |
| Earnings Per Share Diluted | -0.06 | -0.07 | -0.07 | -0.03 | -0.02 | -0.03 |
| Weighted Average Shares Outstanding | 75.11 Million | 81.56 Million | 81.56 Million | 81.56 Million | 81.56 Million | 81.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 81.56 Million | 81.56 Million | 81.56 Million | 81.56 Million | 81.56 Million | 81.56 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -549 Thousand | -3.43 Million | -5.77 Million | -2.13 Million | -2.24 Million | -1.94 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 1.24 Million | 5.09 Million | 1.17 Million | 35 Thousand | 5.42 Million | 2.82 Million |
| Selling, General and Administrative Expenses | 319 Thousand | - | 511 Thousand | 1.22 Million | - | 1.48 Million |
| Research and Development Expenses | - | - | 1000.00 | 1.22 Million | - | - |
| Other Expenses | 922 Thousand | - | 1.33 Million | - | 1.45 Million | - |
| Cost and Expenses | 1.24 Million | 5.09 Million | 1.17 Million | 35 Thousand | 5.42 Million | 2.82 Million |
| Operating Income | -1.24 Million | -849 Thousand | -1.17 Million | 840 Thousand | -5.57 Million | -2.82 Million |
| Interest Expense | - | - | - | - | 39 Thousand | - |
| Income Tax Expense | - | - | -62.58 Thousand | 10.62 Thousand | 336 Thousand | - |
| Earnings before Tax | -1.24 Million | -5.1 Million | -1.18 Million | 20 Thousand | -5.61 Million | -2.82 Million |
| Net Income | -1.24 Million | -5.1 Million | -1.18 Million | 20 Thousand | -5.61 Million | -2.82 Million |
| Earnings Per Share Basic | -0.01 | - | -0.01 | 0.00 | - | -0.03 |
| Earnings Per Share Diluted | -0.01 | - | -0.01 | 0.00 | - | -0.03 |
| Weighted Average Shares Outstanding | 92.83 Million | 81.53 Million | 81.54 Million | 81.63 Million | 81.56 Million | 81.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 92.83 Million | 81.56 Million | 81.54 Million | 81.56 Million | 81.56 Million | 81.55 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.09 Million | - | -1.11 Million | 905.5 Thousand | - | -2.71 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
DPL
8411
VRN
GILD
DOLE
AME